Prot #K-321-201: A Double-Masked, Randomised, Placebo-Controlled, Parallel-Group, 12-Week, Phase 2 Study to Investigate the Safety and Efficacy of Ripasudil (K-321) Eye Drops After Descemetorhexis in Patients with Fuchs Endothelial Corneal Dystrophy

Project: Research project

Project Details

StatusFinished
Effective start/end date9/14/209/14/23

Funding

  • PPD Investigator Services, LLC ((OE) Prot #K-321-201 // (OE) Prot #K-321-201)
  • Kowa Research Institute, Inc. ((OE) Prot #K-321-201 // (OE) Prot #K-321-201)